{"id":"W2102625113","doi":"10.1200/jco.2013.51.1816","title":"Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; EMD Serono; Varian Medical Systems; F. Hoffmann-La Roche; Genentech; AstraZeneca; Celgene; Quest Diagnostics","keywords":"Medicine; Gefitinib; Internal medicine; Hazard ratio; Placebo; Lung cancer; Chemotherapy; Oncology; Cancer; Gastroenterology; Surgery; Epidermal growth factor receptor; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003113737,0.001664135,0.003973322,0.0004752779,0.0004161589,0.0009375901,0.0007484754,0.00147563,0.002940646],"category_scores_gemma":[0.001944391,0.0003629733,0.002670557,0.0004366638,0.0007198749,0.0008586437,0.0003166442,0.001916933,0.0006177948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008223248,"about_ca_system_score_gemma":0.001178354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001036952,"about_ca_topic_score_gemma":0.003101383,"domain_scores_codex":[0.9989336,0.0007115113,0.00006828851,0.0001069222,0.0000878737,0.00009182136],"domain_scores_gemma":[0.998539,0.0003933019,0.0004247261,0.0001027085,0.0001055869,0.0004347365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9593398,0.004359603,0.001404527,0.0007929542,0.002474037,0.00006385291,0.00003971075,0.0003406686,0.002765197,0.00004379315,0.001304535,0.02707137],"study_design_scores_gemma":[0.7725035,0.2038809,0.01703096,0.0001217633,0.003047854,0.0001412498,0.00003299634,0.0004214551,0.0008261611,0.0001222377,0.001838759,0.00003213322],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9505274,0.0413751,0.0004288047,0.0008069144,0.0005831699,0.001704236,0.002208411,0.0001077399,0.002258188],"genre_scores_gemma":[0.9852118,0.008686809,0.0004725414,0.000703763,0.0005287208,0.001070768,0.001852721,0.00002569916,0.001447171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003973322,"threshold_uncertainty_score":0.01646721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1397857239891092,"score_gpt":0.5090334062363405,"score_spread":0.3692476822472313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}